Urothelial carcinoma (UC)
Also known as: Urothelial cell carcinoma / Urothelial Carcinoma / Carcinoma, Urothelial / Transitional cell carcinoma (morphologic abnormality) / Carcinoma transitional cell / Transitional cell carcinoma / Carcinoma, Transitional Cell
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09035 | Nivolumab | Programmed cell death protein 1 | target |
| DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |